@lynxbiosciences.com
LynxBio is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Lynx Biosciences™ is a clinical-stage biotechnology company dedicated to revolutionizing oncology treatments through their innovative approach. The company combines physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics to rapidly advance drug candidates and bring personalized cancer treatments to patients. Lynx Biosciences™ utilizes a multi-omic platform to resolve cancer biology by integrating various data sets and technologies.
Their deep phenotypic profiling and functional characterization of suspension cells enable a comprehensive understanding of complex diseases and treatments, including hematological cancers, immunotherapies, and cell-based therapies. With their proven platform, Lynx Biosciences™ partners with underserved community hospitals, NCI-designated cancer centers, and top pharmaceutical companies to collaborate on clinical studies. By identifying predictive biomarkers and advancing promising drug candidates, they aim to address unmet medical needs in oncology and improve patient outcomes.
For partnership opportunities or further inquiries, please contact Lynx Biosciences™. Stay connected with them to stay updated on the latest news and advancements in personalized cancer treatments
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online